TALPHERA, INC. Cost of Goods Sold (Deprecated 2018-01-31)
TALPHERA, INC. (TLPH) reported Cost of Goods Sold (Deprecated 2018-01-31) of $10.66 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-03-09
- TALPHERA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $962.00K, a 69.57% decline year-over-year.
- TALPHERA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.03M, a 21.33% decline year-over-year.
- TALPHERA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $3.54M, a 19.05% increase year-over-year.
- TALPHERA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $4.13M, a 14.62% increase year-over-year.
- TALPHERA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $10.66M, a 13.45% decline from fiscal 2016.
- TALPHERA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $12.31M, a 595.76% increase from fiscal 2015.
- TALPHERA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $1.77M.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $962.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.99M derived: sum of 2 quarters · filed 2018-03-09 | $6.53M derived: sum of 3 quarters · filed 2018-03-09 | $10.66M 10-K · filed 2018-03-09 |
| 2017-09-30 | $2.03M 10-Q · filed 2017-11-09 | $5.57M derived: sum of 2 quarters · filed 2017-11-09 | $9.70M 10-Q · filed 2017-11-09 | $12.86M derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | $3.54M 10-Q · filed 2017-08-02 | $7.67M 10-Q · filed 2017-08-02 | $10.83M derived: sum of 3 quarters · filed 2018-03-09 | $13.41M derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | $4.13M 10-Q · filed 2017-05-08 | $7.29M derived: sum of 2 quarters · filed 2018-03-09 | $9.87M derived: sum of 3 quarters · filed 2018-03-09 | $12.84M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $5.74M derived: sum of 2 quarters · filed 2018-03-09 | $8.72M derived: sum of 3 quarters · filed 2018-03-09 | $12.31M 10-K · filed 2018-03-09 |
| 2016-09-30 | $2.58M 10-Q · filed 2017-11-09 | $5.55M derived: sum of 2 quarters · filed 2017-11-09 | $9.15M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $2.98M 10-Q · filed 2017-08-02 | $6.58M 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | $3.60M 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | $1.77M 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |